Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
ALGORHYTHM HOLDINGS, INC. ANNOUNCES PRICING OF $9.5 MILLION PUBLIC OFFERING
News
fort lauderdale, fl, dec. 05, 2024 (globe newswire) -- algorhythm holdings, inc. (“algorhythm” or the “company”) (nasdaq: rime), an ai-driven technology and consumer electronics holding company, announced it has priced a public offering with gross proceeds to the company expected to be approximately $9.5 million, before deducting placement agent fees and other estimated expenses payable by the company.
ji'an, jiangxi, china, nov. 01, 2024 (globe newswire) -- universe pharmaceuticals inc (the “company”) (nasdaq: upc), a pharmaceutical producer and distributor in china, today announced that the company received a written notification (the "notification letter") from the nasdaq stock market llc ("nasdaq") on october 25, 2024, notifying the company that it is not in compliance with the minimum bid price requirement set forth in the nasdaq listing rules for continued listing on the nasdaq.
BLUEBIRD BIO ANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT
News
somerville, mass.--(business wire)--bluebird bio, inc. (nasdaq: blue) (“bluebird bio” or the “company”) today announced that it will proceed with a 1-for-20 reverse stock split (“reverse stock split”) of the company's common stock following approval by both its board of directors and blue stockholders at its reconvened annual meeting held on december 4, 2024. as previously announced, the primary goal of the reverse stock split is to increase the per share market price of the company's common st.
SANTECH HOLDINGS LIMITED ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID REQUIREMENT
News
hong kong, dec. 05, 2024 (globe newswire) -- santech holdings limited (nasdaq: stec) (“santech” or the “company”) announced today that it has received an extension of the period to regain compliance with the nasdaq stock market inc.'s (the "nasdaq") the minimum bid price requirement (the “minimum bid price requirement”).
SRM ENTERTAINMENT, INC. ANNOUNCES PRICING OF $1.7 MILLION REGISTERED DIRECT OFFERING
News
jupiter, fl, dec. 05, 2024 (globe newswire) -- srm entertainment, inc. (nasdaq: srm) (the “company,” or “srm”, a leading provider of creative and high-quality licensed media-themed merchandise, today announced that it entered into a securities purchase agreement with a certain institutional investor to purchase approximately $1.7 million shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering at a purchase price of $0.7385 per share.
CNEY ENTERED INTO WARRANT INDUCEMENT AGREEMENTS WITH CERTAIN HOLDERS
News
lishui, china, dec. 5, 2024 /prnewswire/ -- cn energy group. inc. (nasdaq: cney) ("cney" or the "company") today announced that it entered into warrant inducement agreements with certain holders (each, a "holder") of the company's existing ordinary share purchase warrants issued in january 2023 (the "existing warrants"), covering up to an aggregate of 6,576,278 class a ordinary shares of the company, no par value (the "ordinary shares"), pursuant to which (i) the exercise price of the existing warrants will be reduced from $1.4529 per share to $0.32 per share (the "reduced exercise price") to the extent exercised by each holder, and (ii) in exchange for each holder's cash payment of the reduced exercise price of the existing warrants in part or whole, the company will issue new unregistered ordinary share purchase warrants (the "new warrants"), to incentivize the holders to exercise the existing warrants in cash.
RELMADA THERAPEUTICS REPORTS THAT DATA MONITORING COMMITTEE (DMC) ASSESSMENT INDICATES THAT THE PHASE 3 RELIANCE II TRIAL IS FUTILE AT ITS INTERIM ANALYSIS AND IS UNLIKELY TO MEET THE PRIMARY EFFICACY ENDPOINT WITH STATISTICAL SIGNIFICANCE
News
the dmc did not identify any new safety concerns relmada to evaluate potential next steps for the rel-1017 program relmada to continue to focus on the development of rel-p11 for metabolic disease relmada is well capitalized with approximately $54.1 million in cash and cash equivalents as of september 30, 2024 coral gables, fla., dec. 04, 2024 (globe newswire) -- relmada therapeutics, inc. (nasdaq: rlmd, “relmada”, “the company”), a late-stage biotechnology company addressing diseases of the central nervous system (cns), today announced that the pre-planned interim analysis of reliance ii, conducted by the independent data monitoring committee (dmc), indicated that the reliance ii phase 3 study is futile and is unlikely to meet the primary efficacy endpoint with statistical significance.
ZJK INDUSTRIAL CO., LTD. ANNOUNCES PARTIAL EXERCISE OF OVER-ALLOTMENT OPTION
News
shenzhen, china, oct. 30, 2024 (globe newswire) -- zjk industrial co., ltd. (nasdaq: zjk) (the “company”), a high-tech enterprise specialized in manufacturing and sale of precision fasteners, structural parts and other precision metal parts products for new energy vehicles and intelligent electronic equipment, today announced that the underwriters of its initial public offering (the "offering") have partially exercised their over-allotment option to purchase an additional 131,249 ordinary shares at the public offering price of us$5.00 per share. after giving effect to the partial exercise of the over-allotment option, the company sold an aggregate 1,381,249 ordinary shares for gross proceeds of approximately us$6.91 million, before deducting underwriter discounts and other related expenses. the option closing date was october 30, 2024. the ordinary shares began trading on the nasdaq capital market on september 30, 2024, under the ticker symbol "zjk."
SMX (Security Matters) Public Limited Company24 days ago
TRUEGOLD: EMPOWERING THE GOLD INDUSTRY TO NEW LEVELS OF TRANSPARENCY AND VERIFICATION THAT IS BOTH TANGIBLE AND DIGITAL
News
miami, fl / accesswire / november 12, 2024 / truegold, a subsidiary of smx (nasdaq:smx), is revolutionizing the gold industry with its molecular-marking technology. this groundbreaking system, which creates a fully traceable and verifiable supply chain for gold, from mining to the marketplace and recycling, is nothing short of a game-changer that brings a new level of transparency, accountability, and, as importantly, an ability for companies to confidently meet stringent industry standards and verify its exclusive use of ethically sourced gold.
US ARMY BOWL NATIONAL COMBINE POWERED BY SIGNING DAY SPORTS POISED TO BREAK RECORDS IN ATTENDANCE AND IMPACT
News
event to be held december 18-21, 2024, at the star, the dallas cowboys practice facility in frisco, tx event to be held december 18-21, 2024, at the star, the dallas cowboys practice facility in frisco, tx
AUDIOEYE ANNOUNCES PRICING OF SECONDARY OFFERING OF COMMON STOCK BY SELLING STOCKHOLDERS
News
tucson, ariz. , dec. 5, 2024 /prnewswire/ -- audioeye, inc. ("audioeye" or the "company") (nasdaq: aeye), the industry-leading digital accessibility company, today announced the pricing of the previously announced underwritten secondary offering of up to 1,250,000 shares of its common stock to be sold by certain selling stockholders at a price to the public of $24.00 per share, before underwriting discounts and commissions.
APPLIED OPTOELECTRONICS TO PRESENT AT THE RAYMOND JAMES 2024 TMT & CONSUMER CONFERENCE
News
sugar land, texas, nov. 26, 2024 (globe newswire) -- applied optoelectronics, inc. (nasdaq: aaoi), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (ftth) markets, today announced the company will present via a fireside chat at the following investor conference:
MONDEE ANNOUNCES RECEIPT OF NASDAQ DELIST DETERMINATION NOTICE
News
austin, texas, dec. 01, 2024 (globe newswire) -- mondee holdings, inc. (nasdaq: mond) (“mondee” or the “company”), a leading travel marketplace and artificial intelligence (ai) technology company, announced today that the company received a letter from the listing qualifications department (the “staff”) of the nasdaq stock market llc (“nasdaq”) issuing a staff determination (the “staff determination”) on november 27, 2024 after the company informed the staff that it would not contest a delisting of its common stock.
GELTEQ ANNOUNCES LARGEST U.S. CUSTOMER INCREASES INITIAL ORDER BY 50% TO MEET GROWING MARKET DEMAND
News
healthy extracts expands order after high demand for gelteq's collagen and mynus sugar blocker gels healthy extracts expands order after high demand for gelteq's collagen and mynus sugar blocker gels
CALERES REPORTS THIRD QUARTER RESULTS AND UPDATES GUIDANCE
News
st. louis--(business wire)--caleres (nyse: cal), a market-leading portfolio of consumer-driven footwear brands, today reported financial results for the third quarter 2024. reported sales of $740.9 million, down 2.8% year-on-year; famous footwear sales declined 4.8% versus the third quarter of 2023 with comparable store sales up 2.5%; brand portfolio sales increased 0.7% versus the third quarter of 2023; third quarter consolidated gross margin rate of 44.1%, down 55 basis points year-on-year; r.
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF BIODEXA PHARMACEUTICALS PLC - BDRX
News
new york, ny / accesswire / november 27, 2024 / pomerantz llp is investigating claims on behalf of investors of biodexa pharmaceuticals plc ("biodexa" or the "company") (nasdaq:bdrx). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
APOLLOMICS TO PRESENT AT THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE
News
foster city, calif., sept. 04, 2024 (globe newswire) -- apollomics inc. (nasdaq: aplm) (“apollomics” or the “company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced company management will be presenting at the h.c. wainwright 26th annual global investment conference taking place on september 9-11, 2024 virtually and in person at the lotte new york palace hotel in new york, ny.
CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
News
beijing, china / accesswire / november 15, 2024 / casi pharmaceuticals, inc. (nasdaq:casi) ("casi" or the "company"), a cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and pharmaceutical products, today reported business updates and financial results for the three months ended september 30, 2024. dr. wei-wu he, chairman and ceo of casi, said "the third quarter of 2024 marks a period of substantial progress for casi as we continue to refine our company's strategic focus on the development for organ transplant rejection and autoimmune diseases.
COMSTOCK WELCOMES INOVA 360° CONCIERGE MEDICINE TO THE ROW AT RESTON STATION
News
reston, va.--(business wire)--comstock holding companies, inc. (nasdaq: chci) (“comstock”), a leading asset manager, developer, and operator of mixed-use and transit-oriented properties in the washington, d.c. region, announced today the signing of a 4,505 square foot lease with inova 360° concierge medicine (“inova”) at 1880 reston row plaza, located within the row at reston station. inova 360° concierge medicine is designed for individuals seeking a proactive and individualized approach to th.
NLS PHARMACEUTICS LTD. ANNOUNCES PRICING OF PRIVATE PLACEMENT OF UP TO $1 MILLION AT A 15% PREMIUM TO THE MARKET
News
zurich , dec. 4, 2024 /prnewswire/ -- nls pharmaceutics ltd. (nasdaq: nlsp) (nasdaq: nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced the pricing of a private placement offering consisting of the issuance and sale of up to 322,580 common shares only, par value chf 0.80 per share, at a purchase price of $3.10 per common share, for aggregate gross proceeds of up to $1.0 million, subject to shareholder approval.
PURPLE BIOTECH ANNOUNCES CLOSING OF $2.8 MILLION REGISTERED DIRECT OFFERING OF AMERICAN DEPOSITARY SHARES
News
rehovot, israel, dec. 05, 2024 (globe newswire) -- purple biotech ltd. (“purple biotech” or the “company”) (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced the closing of its previously announced registered direct offering of 472,668 of the company's american depositary shares (“adss”), each ads representing 200 ordinary shares, at a purchase price of $6.00 per ads.
ZEO SCIENTIFIX AND EXOTROPIN JOIN FORCES TO LAUNCH A SOLUTION TO ADDRESS THE GROWING UNMET NEED FOR HAIR LOSS
News
fort lauderdale, fl / accesswire / november 13, 2024 / zeo scientifix, inc. ("zeo" or the "company") (otcqb:zeox), a south florida-based clinical-stage biopharmaceutical company, announced it has partnered with its affiliate exotropin, llc, a privately-held company that produces cosmetics, nutraceuticals, and other consumer products to design and deliver a hair growth solution for people who have considered hair transplant surgery. the companies will introduce their first planned collaborative product, zeo hair grow™ powered by exotropin™, at the medical aesthetics professionals (map) meeting being held in scottsdale, arizona, from november 14 - 16, 2024.
VACCINEX REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
News
actively exploring partnership for alzheimer's development supplementary financing concluded in q4 rochester, n.y., nov. 18, 2024 (globe newswire) -- vaccinex, inc. (nasdaq: vcnx), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of semaphorin 4d (sema4d), today announced financial results for the third quarter ended september 30, 2024 and provided a corporate update on its key program for alzheimer's disease.
ANAVEX LIFE SCIENCES TO PRESENT AT THE 7TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE 2024
News
new york, dec. 02, 2024 (globe newswire) -- anavex life sciences corp. (“anavex” or the “company”) (nasdaq: avxl), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of alzheimer's disease, parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including rett syndrome, and other central nervous system (cns) diseases, today announced that christopher u. missling, phd, president and chief executive officer of anavex, will participate in a fireside chat being held december 4th, 2024 at 3:25pm et at the 7th annual evercore isi healthconx conference 2024 in coral gables, fl.
HAOXI HEALTH TECHNOLOGY LIMITED AWARDED A RMB30 MILLLION FRAMEWORK CONTRACT TO PROVIDE DIGITAL ADVERTISING SERVICES FOR TENGYUAN MEDIA ADVERTISING CO., LTD.
News
beijing, nov. 27, 2024 (globe newswire) -- haoxi health technology limited (the “company” or “hao”), an online marketing solution provider headquartered in beijing, china, today announced the company's wholly owned subsidiary beijing haoxi digital technology co., ltd. (“beijing haoxi”) was awarded a recharge service framework contract (the “contract”) to provide comprehensive digital advertising services with a budget of rmb30 million for tengyuan media advertising co., ltd. (“tengyuan") and its clients.
Adlai Nortye Ltd. American Depositary Shares7 months ago
ADLAI NORTYE LTD. TO PRESENT ENCOURAGING DATA OF THE COMBINATION OF AN0025 AND DEFINITIVE CHEMORADIOTHERAPY (DCRT) AT ASCO 2024
News
singapore and north brunswick, n.j. and hangzhou, china, may 23, 2024 (globe newswire) -- adlai nortye ltd. (nasdaq: anl) (the “company” or “adlai nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will present encouraging preliminary data of an0025 in combination with definitive chemoradiotherapy (dcrt) in unresectable locally advanced or locally recurrent esophageal cancer (ec) at the upcoming american society of cancer oncology (asco) annual meeting to be held in chicago from may 31 to june 4, 2024.
AEROVIRONMENT TO ACQUIRE BLUEHALO ESTABLISHING NEXT-GENERATION DEFENSE TECHNOLOGY COMPANY
News
arlington, va.--(business wire)--aerovironment, inc. (nasdaq: avav) (“av” or the “company”) and bluehalo llc (“bluehalo”) today announced the execution of a definitive agreement under which av will acquire bluehalo in an all-stock transaction with an enterprise value of approximately $4.1 billion, creating a more diversified global leader in all-domain defense technologies. the combined company will bring together complementary capabilities to offer a comprehensive portfolio of high-growth fran.
MOBILICOM ENTERS STRATEGIC PARTNERSHIP WITH DT RESEARCH TARGETING THE TACTICAL GROUND CONTROL STATION MARKET FOR SMALL SIZED DRONES AND ROBOTICS IN HARSH ENVIRONMENTS
News
shoham, israel, nov. 13, 2024 (globe newswire) -- mobilicom limited (nasdaq: mob, mobbw), a provider of cybersecurity and robust solutions for drones and robotics, today announced it has entered a strategic partnership to target the ground control station (gcs) market by combining its expertise in secure software and hardware solutions with u.s. silicon valley-based dt research's rugged, high-performance computing technology. the collaboration combines cybersecure communication, gcs expertise, and ruggedized technology to create advanced gcs solutions for uncrewed systems in demanding environments. importantly, the gcs products launched by the partnership are national defense authorization act (ndaa)-compliant, a key requirement for u.s. department of defense procurement, and a qualification of growing importance to allied nations.
ENGLOBAL ANNOUNCES THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS
News
houston, tx / accesswire / november 12, 2024 / englobal corporation (nasdaq:eng), a provider of innovative engineering project solutions focused on the energy industry, today announced it has filed its third quarter 2024 report on form 10-q with the u.s. securities and exchange commission for the three-months ended september 28, 2024. the report details englobal's financial and operational results.
NOTICE OF DELISTING AND RE-COMPLIANCE OF NASDAQ LISTING RULE
News
hong kong, nov. 30, 2024 (globe newswire) -- on november 21, 2024, primega group holdings limited (nasdaq: pghl) (the “company”), was notified by nasdaq listing qualifications staff of the nasdaq stock market llc (“nasdaq”) that the company has not paid a sum of certain fees as required under nasdaq listing rule 5900 series (“delisting notice”). nasdaq listing rule 5250(f) states that “the company is required to pay all applicable fees as described in the rule 5900 series.
BRIGHT GREEN CORPORATION PROVIDES AN UPDATE, REINFORCES COMMITMENT TO SHAREHOLDERS, AND FOCUSES ON GROWTH AND STRATEGIC PARTNERSHIPS
News
grants, new mexico, sept. 19, 2024 (globe newswire) -- bright green corporation (nasdaq: bgxx) (“bright green” or the “company”), today announced that trading of its shares have been suspended from the nasdaq stock exchange (“nasdaq”) after nasdaq cancelled the scheduled september 26, 2024 delist appeal hearing. while this development represents a change in the company's public trading status, bright green remains committed to pursuing its strategic goals and delivering value to its shareholders.
SONNET BIOTHERAPEUTICS ANNOUNCES PUBLICATION DETAILING THE DISCOVERY AND DEVELOPMENT OF SON-1010, AN ALBUMIN-BINDING IL-12 FUSION PROTEIN, DEMONSTRATING ITS MECHANISM OF ACTION
News
pankaj mohan, ceo of sonnet discusses what this publication means in a virtual investor “what this means” segment; access here
MYND LIFE SCIENCES ANNOUNCES STRATEGIC DEBT REDUCTION AND NEW BOARD MEMBER APPOINTMENT
News
vancouver, british columbia--(newsfile corp. - november 22, 2024) - mynd life sciences (cse: mynd) (otcqb: myndf) ("mynd" or the "company"), a leader in mental health diagnostics and treatments, today announced two significant strategic decisions aimed at strengthening the company's financial position and governance. these moves demonstrate a strong commitment to the company's vision and strategic plan to commercialize a diagnostic biomarker test for depression which is being initially developed for the purpose of diagnosing and monitoring those with major depressive disorder (mdd).
PHOENIX MOTOR INC. ANNOUNCES RECEIPT OF NASDAQ DELISTING NOTICE
News
anaheim, ca / accesswire / november 21, 2024 / phoenix motor inc. (nasdaq:pev) (the "company") today announced that it received a delinquency notification letter from the listing qualifications staff of the nasdaq stock market llc ("nasdaq") due to the company's non-compliance with nasdaq listing rule 5250(c)(1) (the "listing rule") as a result of the company's failure to timely file its quarterly report on form 10-q for the quarterly period ended september 30, 2024 (the "form 10-q"). the listing rule requires listed companies to timely file all required periodic financial reports with the securities and exchange commission (the "sec").
UPEXI FILES LITIGATION IN NEVADA AS FIRST STEP IN DETERMINING MANIPULATION OF FRACTIONAL SHARE ROUNDUPS DURING REVERSE STOCK SPLIT
News
tampa, fl / accesswire / november 25, 2024 / upexi, inc. (nasdaq:upxi) (the "company" or "upexi"), a multi-faceted amazon and direct-to-consumer brand owner and innovator in aggregation, announces the company has filed a complaint in the united states district court for the district of nevada to pursue the groups and individuals who orchestrated the manipulative and fraudulent activity in the shares round-up scheme related to upexi's reverse stock split. upexi anticipates that the court, through the discovery process, will enable the company to determine who are the individuals owning the accounts and engaged in the manipulative trading transactions within those accounts in connection with and around the announcement and effective date of upexi's reverse stock split.
PALISADE BIO ANNOUNCES PRELIMINARY DATA FROM PHASE 1 CLINICAL STUDY OF PALI-2108 FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS APPEARS TO BE SAFE AND WELL TOLERATED IN TREATED SUBJECTS
News
first three single ascending dose cohorts demonstrated no treatment related adverse events carlsbad, ca, dec. 03, 2024 (globe newswire) -- palisade bio, inc, (nasdaq: pali) (“palisade,” “palisade bio” or the “company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, today announced preliminary results from its first three single ascending dose (sad) cohorts in its ongoing phase 1 human clinical study for pali-2108 for the treatment of ulcerative colitis (uc). the ongoing phase 1 study is evaluating pali-2108 in a single-center, double-blind, placebo-controlled study focused on safety, tolerability, pharmacokinetics (pk), and pharmacodynamics (pd) in healthy volunteers, alongside an open-label study involving a patient cohort with uc.
CROWN EXPANDS FIBER OPTICS SERVICES FOOTPRINT WITH LEADING REGIONAL INTERNET PROVIDER IN OREGON
News
los angeles, dec. 04, 2024 (globe newswire) -- crown electrokinetics corp. (nasdaq: crkn) (“crown” or the “company”), a leading provider of innovative technology infrastructure solutions that benefit communities and the environment, today announced that its fiber optics division has been issued multiple fiber-to-the-home (ftth) purchase orders with an approximate value of $8 million by a leading regional fiber-optic internet provider, further broadening its footprint in oregon.
ACM RESEARCH ANNOUNCES PARTICIPATION IN 13TH ANNUAL NYC SUMMIT 2024
News
fremont, calif., nov. 29, 2024 (globe newswire) -- acm research, inc. (“acm” or “acm research”) (nasdaq: acmr), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today announced management's participation in the 13th annual nyc summit 2024 investor conference (the “nyc summit”), being held tuesday, december 17, 2024, at mastro's steakhouse new york.
MONOPAR ANNOUNCES FIRST PATIENT DOSED WITH ITS NOVEL THERAPEUTIC RADIOPHARMACEUTICAL MNPR-101-LU
News
wilmette, ill., dec. 05, 2024 (globe newswire) -- monopar therapeutics inc. (nasdaq: mnpr), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced the first patient ever dosed with mnpr-101-lu. this novel therapeutic radiopharmaceutical combines mnpr-101, monopar's antibody that selectively targets the urokinase plasminogen activator receptor (upar), with the therapeutic radioisotope lutetium-177. upar is involved in tumor growth and metastasis, and is found in some of the most aggressive, deadly cancers, including pancreatic, ovarian, triple negative breast, and colorectal cancers.
THE CONTAINER STORE ANNOUNCES GLOBAL LICENSING PARTNERSHIP WITH VACANE HOUSEHOLD COMMODITIES CO., LTD.
News
coppell, texas--(business wire)--the container store (nyse: tcs), the nation's leading retailer of organizing solutions, custom spaces, and in-home services, is expanding its customer favorite everything organizer™ collection internationally through a partnership with vacane household commodities, the strategic partner manufacturing this collection. this marks the first licensing of the container store brand internationally. exclusive to the container store, the everything organizer collection.
VIRACTA THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
News
- reprioritized resources to reduce costs and enhance focus on nana-val's development program in relapsed or refractory ebv-positive peripheral t-cell lymphoma (ptcl) -
AEO INC. REPORTS THIRD QUARTER GROWTH ACROSS BRANDS REFLECTING STRONG EXECUTION ON POWERING PROFITABLE GROWTH PLAN
News
pittsburgh--(business wire)--american eagle outfitters, inc. (nyse: aeo) today announced financial results for the third quarter fiscal 2024 ended november 2, 2024. “building on our positive performance in the first half of the year, third quarter results provide another proof point of the effectiveness of our powering profitable growth plan. led by a strong back-to-school season, we achieved comparable sales growth across brands and channels, and delivered adjusted operating income at the high.
WANG & LEE GROUP, INC. ANNOUNCES FISCAL YEAR 2023 FINANCIAL RESULTS
News
hong kong, china, april 18, 2024 (globe newswire) -- wang & lee group, inc. (nasdaq: wlgs) (“wlgs” or the “company”), is a british virgin islands holding company with operations conducted by its subsidiaries in hong kong. the company is a construction prime and subcontractor engaging in the installation of electrical & mechanical systems (“e&m”), which include low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning (“mvac”) systems, fire service systems, water supply and sewage disposal system installation and fitting out for the public and private sectors. the company today announced its unaudited operating results for the year ended december 31, 2023.
News
8 months ago
-
In terms of stock market analysis, 'top losers" are stocks that have experienced significant declines in their market value over a specified period, often expressed as a percentage decrease from their previous closing prices.
The concept of top losers is of paramount importance to investors and market participants, offering valuable insights and implications. Top losers signify stocks that have performed poorly due to various factors, such as poor financial results, adverse news, economic downturns, or industry-specific challenges. For investors holding these stocks, they translate into financial losses, which can be especially consequential for short-term traders.
The significance of top losers extends beyond individual investors. They serve as broader indicators of market sentiment and trends. When a notable number of stocks feature as top losers, it may suggest broader market weakness or shifts in investor sentiment. This information is invaluable for strategic decision-making. Moreover, top losers underscore the inherent volatility in financial markets. This volatility presents opportunities for active traders who capitalize on short-term fluctuations.
However, such trading strategies require careful consideration and in-depth research. For some investors, top losers represent contrarian opportunities. They may see value in purchasing stocks at reduced prices, anticipating future recoveries. Yet, this approach demands meticulous analysis and a strong belief in a stock's long-term prospects.
Benefits of Tracking Daily Top Losers
Staying informed about the daily top losers in the stock market can yield substantial benefits for traders and investors alike, arguably even more than knowing the top gainers for the day. This is because tracking top losers serves as a crucial aspect of market awareness and informed decision-making.
Firstly, monitoring the top losers provides a real-time gauge of market sentiment and potential risks. A sudden surge in the number or volume of stocks appearing in the top losers list can signal broader market weaknesses or the onset of a bearish trend. This information about unusual volume is invaluable for traders who may choose to adjust their strategies or exit positions to mitigate losses.
Secondly, for active traders, top losers represent potential short-term trading opportunities. Volatility tends to be higher among these stocks, offering the possibility of profit through short selling or other trading strategies. Traders who specialize in technical analysis may find these stocks particularly interesting for short-term gains.
Furthermore, understanding the reasons behind a stock's decline among the top losers can provide insights into industry-specific challenges, corporate governance issues, or broader economic trends. This knowledge enables investors to make more informed decisions about their portfolios and sector allocations.
Unleashing Contrarian Investing
Contrarian investing is a bold strategic approach within the stock market that runs counter to the prevailing sentiment. Instead of following the crowd and investing in the market's top performers or winners, contrarian investors deliberately seek out assets that have experienced significant declines or are considered the "top losers.”
The fundamental idea behind the contrarian philosophy of investing involves purchasing assets when they are being sold by others and selling them when they are being bought by others. This strategy revolves around the expectation that market sentiment frequently fluctuates to the point of extremes resulting in either overvaluation or undervaluation of assets.
Assuming US stocks or sectors experience a significant downturn and become top losers, contrarian investors see an opportunity to buy assets at lower prices, anticipating a potential reversal in their fortunes.
Contrarian investors conduct in-depth research and analysis to identify situations where market sentiment has caused an asset to be unfairly undervalued. They look for factors such as overselling, negative news sentiment, or widespread pessimism that may have driven down prices beyond their intrinsic value. By going against the prevailing sentiment, contrarians aim to profit from the eventual correction or rebound in the asset's price.
Investor Psychology and Panic Selling
Investor psychology and panic selling are essential aspects of understanding the concept of "top losers" in the stock market. When stocks experience significant losses, it often triggers emotional responses among investors, which can lead to panic selling, typical seen during notable milestones on the earnings calendar or during analyst upgrades and downgrades.
Investor psychology plays a crucial role in stock market dynamics. It encompasses the emotions, behaviors, and cognitive biases that influence investors' decisions. When stocks in a portfolio start to underperform, fear and anxiety may set in. Investors often feel the pressure to protect their capital, leading to impulsive actions.
Panic selling, in particular, is a reaction to steep declines in stock prices. Investors, gripped by fear, rush to sell their holdings, fearing further losses. This mass selling can exacerbate market declines and create a self-fulfilling prophecy. It's a manifestation of herd mentality, where investors follow the crowd, often at the expense of sound judgment.
The relationship between investor psychology, panic selling, and top losers is evident when stocks or asset classes experience sharp declines. Investors may hastily exit positions in these "top losers" to limit losses or avoid further pain. However, this knee-jerk reaction can sometimes lead to missed opportunities for recovery, as markets can be highly volatile and subject to sudden reversals.
Understanding the psychological aspect of investing is crucial for investors. It allows them to make more rational decisions and avoid falling into the trap of panic selling during market downturns. It's essential to have a well-thought-out investment strategy, diversify a portfolio, and set clear goals to navigate the challenges posed by top losers and market turbulence.
Frequently Asked Questions
What Is A Stock Market?
The stock market is a financial market where companies issue stocks and sell them to investors for a price. Individuals and organizations can buy and sell stocks, which is referred to as “buying” or “selling” a stock. Buying and selling stocks can be done through online brokers or in person at a brokerage firm. When buying a stock, investors agree to purchase a certain number of shares of that company at a set price in the future. When selling a stock, they agree to sell all or some of the shares they have currently purchased at the current price.
How Stocks Are Different From Other Investments?
The stock market is a way of investing in companies. Buying shares in a company gives you a share in that company, and you can buy and sell those shares like you would buy and sell any other type of investment. The main difference between stocks and other investments is that when you buy shares in a public company, you are also buying a piece of that company's future earnings. You can think about the stock market as a way of betting on which companies will be the best performers over time.
Can you get rich off stocks?
The stock market is one of the most exciting parts of investing. In just a few hours, you can go from owning nothing to being a millionaire. And who wouldn’t want to be able to make that kind of money so quickly? The main purpose of investing in the stock market is to earn profits by selling your investments after you buy them. The more successful you are at this, the more money you make. If you are not successful, then you lose money on your investment. This may cause people to panic when they see their portfolio prices going down, but it is important to stay calm and focus on making rational decisions while keeping an eye on short-term performance.
Are There Any Risks Involved?
The problem is, there are a lot of scammers out there looking to take advantage of people who are just getting started. So, before you invest your money, make sure you’re doing it the right way. To help you stay safe while you’re on this journey, you should put together a list of things to keep in mind. First and foremost, only invest what you can afford to lose. It’s easy to get swept up in the excitement and forget that your investment is only as secure as your bank account balance. A key aspect of investing in the stock market is learning about how the different types of investments work and how they are different from each other, such as bonds vs stocks vs real estate vs commodities vs derivatives. Another important concept is diversification, which refers to allocating some of your money across different investments so that you don't end up losing everything.
What is the normal trading timings of NASDAQ and NYSE?
The regular market hours are during the hours when the stock market is open, and they begin at 9:30 a.m. and close at 4 p.m., except stock market holidays. During the regular market hours, anything can happen, whether good or bad, that can influence the pricing of the stocks.
How can I see stocks in real time?
You can track the markets on real-time streaming data from Stockstelegraph.com. Be sure to check out the latest gainers and losers as well as dividend stocks and other investment tips. There are several ways you can follow the stock market on a live basis. You can go to NASDAQ or Yahoo Finance to get real-time updates on top gainers and losers as well as dividend stocks and other investment tips. If you don't have access to these resources, you can also use Google Finance which is another popular website that offers real-time streaming data.
What Are Hot Stocks?
Hot stocks are stocks that are in high demand and that investors are eager to buy. Most of the time, this kind of demand for a stock happens before an IPO or because the stock consistently does better than the market because of good financial results.
What Does Market Movers Mean?
Stocks that have made significant changes during the regular trading session are called market movers. They are often used to get a sense of how investors feel. Market movers can also be used to find stocks that were affected by breaking news or to see if the stock is going through any big changes.
What stocks are volatile now?
You can use a stock screener like StocksTelegraph screener to help you find stocks that are often volatile. You can also do research in the middle of the trading day to find out which stocks are changing the most.
